Survival experience of the population needing hospital treatment for asthma or COPD at age 50-54 years

被引:16
|
作者
Keistinen, T
Tuuponen, T
Kivela, SL
机构
[1] Univ Oulu, Dept Publ Hlth Sci & Gen Practice, FIN-90220 Oulu, Finland
[2] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland
关键词
D O I
10.1016/S0954-6111(98)90310-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim was to evaluate the differences of mortality among asthma and COPD patients on the basis of the first period of hospitalization of these diseases. A total of 576 916 treatment periods for asthma and COPD between 1972 and 1992 were identified in the discharge register maintained by the National Research and Development Centre for Welfare and Health. Patients aged 50-54 years first treated in hospital in 1977 or later were analysed. There were 6655 new asthma patients of this age, 2727 new COPD patients and 701 new patients in a mixed group (with both diagnoses). Mortality up to the end of 1993 was analysed based on mortality and cause of death data provided by the Central Statistical Office of Finland. Estimated cumulative survival after 10 yr was higher among the asthma patients (83.5% for men and 93.2% for women) and lower among the COPD patients (60.1% and 78.0%) and in the mixed group (62.5% and 74.4%). The main cause of death among the asthmatics was asthma in 12.1% of cases, that among the COPD patients was COPD in 22.1% of cases and that in the mixed group was one or other of these diseases in 39.1% of cases. The prognosis for COPD patients aged 50-54 years requiring hospital treatment is poor. Combination of the data available from the cause of death and hospital discharge registers indicates that obstructive pulmonary diseases may well be of more significance from a public health point of view than the mortality statistics would lead us to believe. The very first hospitalization for COPD calls for a thorough evaluation of the prospects for active treatment and prevention.
引用
收藏
页码:568 / 572
页数:5
相关论文
共 19 条
  • [11] 30-year survival among patients with myocardial infarction before 50 years of age compared with the general population: a nationwide cohort study
    Schmidt, M.
    Szepligeti, S.
    Hovath-Puho, E.
    Botker, H.
    Sorensen, H. T.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 330 - 331
  • [12] Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades
    Cokgezer, Simay
    Elverdi, Tugrul
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Ongoren, Seniz
    Baslar, Zafer
    Eskazan, Ahmet Emre
    [J]. CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1911 - 1921
  • [13] Treatment Responses, Toxicity and Survival in Patients with Classical Hodgkin Lymphoma Aged 50 Years and Older: A Single-Center Experience over 2 Decades
    Cokgezer, Simay
    Elverdi, Tugrul
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Ongoren, Seniz
    Baslar, Zafer
    Eskazan, Ahmet Emre
    [J]. BLOOD, 2021, 138
  • [14] Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience
    Heiblig, Mael
    Le Jeune, Caroline
    Elhamri, Mohamed
    Balsat, Marie
    Tigaud, Isabelle
    Plesa, Adriana
    Barraco, Fiorenza
    Labussiere, Helene
    Ducastelle, Sophie
    Nicolini, Franck
    Wattel, Eric
    Salles, Gilles
    Thomas, Xavier
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 110 - 117
  • [15] Changes in bicycle ergometer test performance and survival in men and women from 50 to 60 and from 70 to 80 years of age:: Two longitudinal studies in the Glostrup (Denmark) population
    Era, P
    Schroll, M
    Hagerup, L
    Jürgensen, KSL
    [J]. GERONTOLOGY, 2001, 47 (03) : 136 - 144
  • [16] Clinical treatment score post-5 years (CTS5) and the prediction of survival benefit from extended endocrine therapy for breast cancer patients under and over 50 years of age
    Ahn, Jee Hyun
    Park, Jung Min
    Choi, Soon Bo
    Go, Jieon
    Kim, Jee Ye
    Park, Hyung Seok
    Kim, Seung Il
    Park, Byeong-Woo
    Park, Seho
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [17] Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening
    Misra, JS
    Gupta, HP
    Das, V
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2004, 31 (06) : 376 - 379
  • [18] Population Based Analysis of Outcomes of Primary Central Nervous System Lymphoma (PCNSL) Suggests a Treatment Strategy Including Intensive Chemotherapy with Autologous Stem Cell Transplantation Provides a Survival Advantage for Patients <65 Years of Age
    Graczyk, Joanna
    Ghosh, Sunita
    Chua, Neil
    Stewart, Douglas A.
    Owen, Carolyn J.
    [J]. BLOOD, 2014, 124 (21)